REGENERON PHARMACEUTICALS, INC. Operating Income
REGENERON PHARMACEUTICALS, INC. (REGN) reported Operating Income of $1.29 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-06-30 was $1.29B, a 19.82% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-03-31 was $642.90M, a 8.65% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-12-31 was $879.90M, a 11.14% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-09-30 was $1.03B, a 12.95% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. operating income (loss) for fiscal 2025 was $3.58B, a 10.34% decline from fiscal 2024.
- REGENERON PHARMACEUTICALS, INC. operating income (loss) for fiscal 2024 was $3.99B, a 1.39% decline from fiscal 2023.
- REGENERON PHARMACEUTICALS, INC. operating income (loss) for fiscal 2023 was $4.05B, a 14.60% decline from fiscal 2022.
- REGENERON PHARMACEUTICALS, INC. operating income (loss) for fiscal 2022 was $4.74B, a 47.03% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.29B 10-Q · filed 2026-07-30 | $1.94B 10-Q · filed 2026-07-30 | $2.82B derived: sum of 3 quarters · filed 2026-07-30 | $3.84B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $642.90M 10-Q · filed 2026-04-29 | $1.52B derived: sum of 2 quarters · filed 2026-04-29 | $2.55B derived: sum of 3 quarters · filed 2026-04-29 | $3.63B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $879.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $1.91B derived: sum of 2 quarters · filed 2026-02-04 | $2.99B derived: sum of 3 quarters · filed 2026-07-30 | $3.58B 10-K · filed 2026-02-04 | ||||
| 2025-09-30 | $1.03B 10-Q · filed 2025-10-28 | $2.11B derived: sum of 2 quarters · filed 2026-07-30 | $2.70B 10-Q · filed 2025-10-28 | $3.69B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $1.08B 10-Q · filed 2026-07-30 | $1.67B 10-Q · filed 2026-07-30 | $2.66B derived: sum of 3 quarters · filed 2026-07-30 | $3.84B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $591.70M 10-Q · filed 2026-04-29 | $1.58B derived: sum of 2 quarters · filed 2026-04-29 | $2.76B derived: sum of 3 quarters · filed 2026-04-29 | $3.83B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $990.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $2.17B derived: sum of 2 quarters · filed 2026-02-04 | $3.24B derived: sum of 3 quarters · filed 2026-02-04 | $3.99B 10-K · filed 2026-02-04 | ||||
| 2024-09-30 | $1.18B 10-Q · filed 2025-10-28 | $2.25B derived: sum of 2 quarters · filed 2025-10-28 | $3.00B 10-Q · filed 2025-10-28 | $3.97B derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-06-30 | $1.07B 10-Q · filed 2025-08-01 | $1.82B 10-Q · filed 2025-08-01 | $2.79B derived: sum of 3 quarters · filed 2026-02-04 | $3.90B derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-03-31 | $751.40M 10-Q · filed 2025-04-29 | $1.72B derived: sum of 2 quarters · filed 2026-02-04 | $2.84B derived: sum of 3 quarters · filed 2026-02-04 | $3.85B derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2023-12-31 | $972.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $2.08B derived: sum of 2 quarters · filed 2026-02-04 | $3.10B derived: sum of 3 quarters · filed 2026-02-04 | $4.05B 10-K · filed 2026-02-04 | ||||
| 2023-09-30 | $1.11B 10-Q · filed 2024-10-31 | $2.13B derived: sum of 2 quarters · filed 2024-10-31 | $3.07B 10-Q · filed 2024-10-31 | $4.22B derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-06-30 | $1.02B 10-Q · filed 2024-08-01 | $1.96B 10-Q · filed 2024-08-01 | $3.11B derived: sum of 3 quarters · filed 2025-02-05 | $4.33B derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-03-31 | $946.70M 10-Q · filed 2024-05-02 | $2.09B derived: sum of 2 quarters · filed 2025-02-05 | $3.32B derived: sum of 3 quarters · filed 2025-02-05 | $4.43B derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2022-12-31 | $1.15B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $2.37B derived: sum of 2 quarters · filed 2025-02-05 | $3.48B derived: sum of 3 quarters · filed 2025-02-05 | $4.74B 10-K · filed 2025-02-05 | ||||
| 2022-09-30 | $1.22B 10-Q · filed 2023-11-02 | $2.33B derived: sum of 2 quarters · filed 2023-11-02 | $3.59B 10-Q · filed 2023-11-02 | $6.23B derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-06-30 | $1.11B 10-Q · filed 2023-08-03 | $2.37B 10-Q · filed 2023-08-03 | $5.01B derived: sum of 3 quarters · filed 2024-02-05 | $6.86B derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-03-31 | $1.26B 10-Q · filed 2023-05-04 | $3.90B derived: sum of 2 quarters · filed 2024-02-05 | $5.75B derived: sum of 3 quarters · filed 2024-02-05 | $9.09B derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2021-12-31 | $2.64B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | $4.49B derived: sum of 2 quarters · filed 2024-02-05 | $7.83B derived: sum of 3 quarters · filed 2024-02-05 | $8.95B 10-K · filed 2024-02-05 | ||||
| 2021-09-30 | $1.85B 10-Q · filed 2022-11-03 | $5.19B derived: sum of 2 quarters · filed 2022-11-03 | $6.31B 10-Q · filed 2022-11-03 | $7.47B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-06-30 | $3.35B 10-Q · filed 2022-08-03 | $4.46B 10-Q · filed 2022-08-03 | $5.63B derived: sum of 3 quarters · filed 2023-02-06 | $6.68B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-03-31 | $1.11B 10-Q · filed 2022-05-04 | $2.28B derived: sum of 2 quarters · filed 2023-02-06 | $3.33B derived: sum of 3 quarters · filed 2023-02-06 | $3.99B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2020-12-31 | $1.17B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-06 | $2.22B derived: sum of 2 quarters · filed 2023-02-06 | $2.88B derived: sum of 3 quarters · filed 2023-02-06 | $3.58B 10-K · filed 2023-02-06 | ||||
| 2020-09-30 | $1.05B 10-Q · filed 2021-11-04 | $1.71B derived: sum of 2 quarters · filed 2021-11-04 | $2.41B 10-Q · filed 2021-11-04 | $3.09B derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-06-30 | $656.40M 10-Q · filed 2021-08-05 | $1.36B 10-Q · filed 2021-08-05 | $2.03B derived: sum of 3 quarters · filed 2022-02-07 | $2.77B derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-03-31 | $700.10M 10-Q · filed 2021-05-06 | $1.38B derived: sum of 2 quarters · filed 2022-02-07 | $2.11B derived: sum of 3 quarters · filed 2022-02-07 | $2.43B derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2019-12-31 | $675.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-07 | $1.41B derived: sum of 2 quarters · filed 2022-02-07 | $1.73B derived: sum of 3 quarters · filed 2022-02-07 | $2.21B 10-K · filed 2022-02-07 | ||||
| 2019-09-30 | $738.50M 10-Q · filed 2020-11-05 | $1.05B derived: sum of 2 quarters · filed 2020-11-05 | $1.53B 10-Q · filed 2020-11-05 | $2.25B derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-06-30 | $315.60M 10-Q · filed 2020-08-05 | $795.60M 10-Q · filed 2020-08-05 | $1.51B derived: sum of 3 quarters · filed 2021-02-08 | $2.14B derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-03-31 | $480.00M 10-Q · filed 2020-05-05 | $1.20B derived: sum of 2 quarters · filed 2021-02-08 | $1.82B derived: sum of 3 quarters · filed 2021-02-08 | $2.45B derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2018-12-31 | $718.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | $1.34B derived: sum of 2 quarters · filed 2021-02-08 | $1.97B derived: sum of 3 quarters · filed 2021-02-08 | $2.53B 10-K · filed 2021-02-08 | ||||
| 2018-09-30 | $626.90M 10-Q · filed 2019-11-05 | $626.92M 10-Q · filed 2018-11-06 | $1.25B derived: sum of 2 quarters · filed 2019-11-05 | $1.82B 10-Q · filed 2019-11-05 | $1.82B 10-Q · filed 2018-11-06 | $2.36B derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-06-30 | $622.20M 10-Q · filed 2019-08-06 | $622.19M 10-Q · filed 2018-08-02 | $1.19B 10-Q · filed 2019-08-06 | $1.19B 10-Q · filed 2018-08-02 | $1.73B derived: sum of 3 quarters · filed 2020-02-07 | $2.29B derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-03-31 | $567.20M 10-Q · filed 2019-05-07 | $567.23M 10-Q · filed 2018-05-03 | $1.11B derived: sum of 2 quarters · filed 2020-02-07 | $1.67B derived: sum of 3 quarters · filed 2020-02-07 | $2.22B derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | $538.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $1.10B derived: sum of 2 quarters · filed 2020-02-07 | $1.65B derived: sum of 3 quarters · filed 2020-02-07 | $2.08B 10-K · filed 2020-02-07 | $2.08B 10-K · filed 2018-02-08 | |||
| 2017-09-30 | $559.93M 10-Q · filed 2018-11-06 | $1.11B derived: sum of 2 quarters · filed 2018-11-06 | $1.54B 10-Q · filed 2018-11-06 | $1.89B derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-06-30 | $550.31M 10-Q · filed 2018-08-02 | $980.85M 10-Q · filed 2018-08-02 | $1.33B derived: sum of 3 quarters · filed 2019-02-07 | $1.69B derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-03-31 | $430.54M 10-Q · filed 2018-05-03 | $777.50M derived: sum of 2 quarters · filed 2019-02-07 | $1.14B derived: sum of 3 quarters · filed 2019-02-07 | $1.43B derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2016-12-31 | $346.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | $709.76M derived: sum of 2 quarters · filed 2019-02-07 | $1.00B derived: sum of 3 quarters · filed 2019-02-07 | $1.33B 10-K · filed 2019-02-07 | $1.33B 10-K · filed 2017-02-09 | |||
| 2016-09-30 | $362.80M 10-Q · filed 2017-11-08 | $654.43M derived: sum of 2 quarters · filed 2017-11-08 | $983.74M 10-Q · filed 2017-11-08 | $1.21B derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-06-30 | $291.63M 10-Q · filed 2017-08-03 | $620.94M 10-Q · filed 2017-08-03 | $852.02M derived: sum of 3 quarters · filed 2018-02-08 | $1.24B derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-03-31 | $329.31M 10-Q · filed 2017-05-04 | $560.39M derived: sum of 2 quarters · filed 2018-02-08 | $952.81M derived: sum of 3 quarters · filed 2018-02-08 | $1.30B derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2015-12-31 | $231.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | $623.50M derived: sum of 2 quarters · filed 2018-02-08 | $968.36M derived: sum of 3 quarters · filed 2018-02-08 | $1.25B 10-K · filed 2018-02-08 | ||||
| 2015-09-30 | $392.42M 10-Q · filed 2016-11-04 | $737.28M derived: sum of 2 quarters · filed 2016-11-04 | $1.02B 10-Q · filed 2016-11-04 | $1.24B derived: sum of 4 quarters · filed 2016-11-04 | ||||
| 2015-06-30 | $344.86M 10-Q · filed 2016-08-04 | $628.41M 10-Q · filed 2016-08-04 | $844.22M derived: sum of 3 quarters · filed 2016-08-04 | $1.03B derived: sum of 4 quarters · filed 2016-08-04 | ||||
| 2015-03-31 | $283.55M 10-Q · filed 2016-05-05 | $499.36M derived: sum of 2 quarters · filed 2016-05-05 | $687.82M derived: sum of 3 quarters · filed 2016-05-05 | $915.91M derived: sum of 4 quarters · filed 2016-05-05 | ||||
| 2014-12-31 | $215.80M 10-Q · filed 2015-11-04 | $404.27M derived: sum of 2 quarters · filed 2015-11-04 | $632.36M derived: sum of 3 quarters · filed 2015-11-04 | $823.92M 10-K · filed 2017-02-09 | $838.43M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $188.46M 10-Q · filed 2015-11-04 | $182.72M 10-Q · filed 2014-11-04 | $416.55M derived: sum of 2 quarters · filed 2015-11-04 | $608.12M 10-Q · filed 2015-11-04 | $591.06M 10-Q · filed 2014-11-04 | $803.21M derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-06-30 | $228.09M 10-Q · filed 2015-08-04 | $222.41M 10-Q · filed 2014-08-05 | $419.65M 10-Q · filed 2015-08-04 | $408.35M 10-Q · filed 2014-08-05 | $614.75M derived: sum of 3 quarters · filed 2016-02-11 | $851.55M derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-03-31 | $191.56M 10-Q · filed 2015-05-07 | $185.94M 10-Q · filed 2014-05-08 | $386.66M derived: sum of 2 quarters · filed 2016-02-11 | $623.46M derived: sum of 3 quarters · filed 2016-02-11 | $781.56M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-12-31 | $195.09M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $431.90M derived: sum of 2 quarters · filed 2016-02-11 | $590.00M derived: sum of 3 quarters · filed 2016-02-11 | $743.05M 10-K · filed 2016-02-11 | $760.03M 10-K · filed 2014-02-13 | |||
| 2013-09-30 | $236.80M 10-Q · filed 2014-11-04 | $394.90M derived: sum of 2 quarters · filed 2014-11-04 | $547.96M 10-Q · filed 2014-11-04 | $693.63M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $158.10M 10-Q · filed 2014-08-05 | $311.15M 10-Q · filed 2014-08-05 | $456.82M derived: sum of 3 quarters · filed 2015-02-12 | $659.19M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $153.05M 10-Q · filed 2014-05-08 | $298.72M derived: sum of 2 quarters · filed 2015-02-12 | $501.08M derived: sum of 3 quarters · filed 2015-02-12 | $588.56M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | $145.67M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $348.03M derived: sum of 2 quarters · filed 2015-02-12 | $435.51M derived: sum of 3 quarters · filed 2015-02-12 | $457.71M 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | $202.36M 10-Q · filed 2013-11-05 | $289.84M derived: sum of 2 quarters · filed 2013-11-05 | $312.04M 10-Q · filed 2013-11-05 | $266.64M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-06-30 | $87.48M 10-Q · filed 2013-08-06 | $109.68M 10-Q · filed 2013-08-06 | $64.28M derived: sum of 3 quarters · filed 2014-02-13 | $5.82M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-03-31 | $22.20M 10-Q · filed 2013-05-03 | -$23.20M derived: sum of 2 quarters · filed 2014-02-13 | -$81.66M derived: sum of 3 quarters · filed 2014-02-13 | -$141.98M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2011-12-31 | -$45.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | -$103.86M derived: sum of 2 quarters · filed 2014-02-13 | -$164.18M derived: sum of 3 quarters · filed 2014-02-13 | -$205.16M 10-K · filed 2014-02-13 | ||||
| 2011-09-30 | -$58.46M 10-Q · filed 2012-10-24 | -$118.78M derived: sum of 2 quarters · filed 2012-10-24 | -$159.76M 10-Q · filed 2012-10-24 | -$172.53M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | -$60.32M 10-Q · filed 2012-07-25 | -$101.30M 10-Q · filed 2012-07-25 | -$114.08M derived: sum of 3 quarters · filed 2013-02-15 | -$146.17M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-03-31 | -$40.98M 10-Q · filed 2012-04-26 | -$53.76M derived: sum of 2 quarters · filed 2013-02-15 | -$85.85M derived: sum of 3 quarters · filed 2013-02-15 | -$109.58M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2010-12-31 | -$12.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | -$44.87M derived: sum of 2 quarters · filed 2013-02-15 | -$68.59M derived: sum of 3 quarters · filed 2013-02-15 | -$97.47M 10-K · filed 2013-02-15 | ||||
| 2010-09-30 | -$32.09M 10-Q · filed 2011-10-27 | -$55.82M derived: sum of 2 quarters · filed 2011-10-27 | -$84.69M 10-Q · filed 2011-10-27 | -$124.10M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-06-30 | -$23.72M 10-Q · filed 2011-07-28 | -$52.60M 10-Q · filed 2011-07-28 | -$92.01M derived: sum of 3 quarters · filed 2012-02-21 | -$93.30M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | -$28.88M 10-Q · filed 2011-05-03 | -$68.28M derived: sum of 2 quarters · filed 2012-02-21 | -$69.58M derived: sum of 3 quarters · filed 2012-02-21 | -$85.84M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2009-12-31 | -$39.41M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | -$40.70M derived: sum of 2 quarters · filed 2012-02-21 | -$56.97M derived: sum of 3 quarters · filed 2012-02-21 | -$74.10M 10-K · filed 2012-02-21 | ||||
| 2009-09-30 | -$1.29M 10-Q · filed 2010-10-28 | -$17.56M derived: sum of 2 quarters · filed 2010-10-28 | -$34.70M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | -$16.27M 10-Q · filed 2010-07-28 | -$33.40M 10-Q · filed 2010-07-28 | ||||||
| 2008-12-31 | -$86.25M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |